secwatch.observer — SEC 8-K summary
======================================

Issuer:     MedAvail Holdings, Inc. (—)
CIK:        0001402479
Form:       8-K
Filed at:   2023-01-26T23:59:59+00:00
Accession:  0001402479-23-000005
Event type: m_and_a
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 2.01, 2.02, 2.05, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MedAvail sells SpotRx pharmacy assets to CVS for up to $4.4M; expects ~$2.5M debt post-close
--------------------------------------------------------------------------------

- Purchase price up to $4.4M; deal expected to close in Q1 2023.
- Sells assets from 8 SpotRx pharmacies in AZ, CA, MI, FL.
- Estimated year-end 2022 cash/investments $10-11M; remaining debt ~$2.5M after closing.
- One-time restructuring costs in H1 2023 ~$6.5M, excluding loan paydown.
- Company evaluating financing options, including with existing shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402479/000140247923000005/0001402479-23-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402479/000140247923000005/medavail-20230122.htm
  HTML page:      https://secwatch.observer/filing/0001402479-23-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer